RNA methylation in development and disease

Add to your list(s) Download to your calendar using vCal

• Michaela Frye, Stem Cell Institute and Department of Genetics, Cambridge
• Tuesday 22 November 2016, 11:00-12:00
• Max Perutz Lecture Theatre, Medical Research Council (MRC) (MRC Laboratory of Molecular Biol.

If you have a question about this talk, please contact Scientific Meetings Co-ordinator.

This talk has been canceled/deleted

Many of the over 100 types of chemical RNA modifications identified in organism of all kingdoms of life are are functionally indispensable for protein synthesis because they regulate translational speed and accuracy. Accordingly, loss-of-function mutations in enzymes responsible for the formation of RNA modifications can cause severe human diseases including neuro-developmental disorders, mitochondrial diseases, diabetes, and cancer. Here, I will focus on the formation of 5-methylcytidine in RNA and show how loss of RNA methylation mechanistically affects protein translation and thereby regulates the cellular response to environmental stress stimuli. This is important because these newly discovered biological roles of RNA methylation directly influence cell fate decision in normal tissue development and tumour formation.

This talk is part of the MRC LMB Seminar Series series.

This talk is included in these lists:

This talk is not included in any other list

Note that ex-directory lists are not shown.